Brief: Mersana Therapeutics Q3 EPS USD -0.09
13/11/2024 12:01
Nov 13 (Reuters) - Mersana Therapeutics Q3 net income USD -11.501 million. * Q3 collaboration revenue USD 12.598 million
MRSN — Mersana Therapeutics News Story
0.000.00%
Last trade - 00:00- $145.16m
- $88.77m
- $40.50m